Company news

KPC Pharmaceuticals, Inc. news in 2026

KPC Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.

View company

(600422)"KPC PHARMACEUTICALS, INC."Report for Q3 2026

October 23, 2026

(600422)"KPC PHARMACEUTICALS, INC."Announcement on Resolutions of the 24th Meeting of the 11th Board of Directors

October 23, 2026

(600422)"KPC PHARMACEUTICALS, INC."Announcement on Provision for Asset Impairment

October 23, 2026

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

September 11, 2026

Announcement on Receipt of the Notice of Registration Acceptance from the National Association of Financial Market Institutional Investors

September 1, 2026

Announcement on Convening the 2026 Semi-annual Performance Briefing

August 27, 2026

Announcement on Amendments to the Articles of Association

August 21, 2026

Announcement on Resolutions of the 21st Meeting of the 11th Board of Directors

July 24, 2026

Announcement on Implementation of Dividend Distribution for 2025

July 21, 2026

Semi-annual Performance Forecast for 2026

July 14, 2026

Announcement on Inclusion of the Company's Products in the "National Essential Medicines List (2026 Edition)"

July 10, 2026

Announcement on Resolutions of the 20th Meeting of the 11th Board of Directors

June 29, 2026

Announcement on Remuneration Plan for Directors and Senior Management Members in 2026

June 8, 2026

Indicative Announcement on Controlling Shareholder's Equity Change Reaching 1% Scale

May 14, 2026

Report for Q1 2026

April 24, 2026

Announcement on Obtaining Drug Registration Certificate

April 20, 2026

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

April 17, 2026

Announcement on Change of Senior Management Member

March 31, 2026

Indicative Announcement on the Publication of the 2025 Performance Announcement by CR Pharmaceutical Group Co., Ltd., an Indirectly Controlling Shareholder of the Controlling Shareholder

March 25, 2026

Notice on Convening the 1st Extraordinary General Meeting in 2026

March 23, 2026

Announcement on Change of Partial Directors and Senior Management Members

March 19, 2026

Preliminary Earnings Estimate for 2025

February 6, 2026

Announcement on Resignation of Director

January 7, 2026

Announcement on Change of Chairman

January 5, 2026